Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07641881 · ClinicalTrials.gov registry record · Phase 1
A Bioequivalence Study Between Two Casdatifan Tablet Strengths and Food Effect Study of Casdatifan in Healthy Adult Participants
A Phase 1 study, sponsored by Arcus Biosciences.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT07641881 is a Phase 1 study that is actively recruiting participants, run by Arcus Biosciences. The registered enrollment target is 24 participants.
The verdict
NCT07641881, a Phase 1 study, is actively recruiting participants, sponsored by Arcus Biosciences.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the single-dose pharmacokinetics (PK) of casdatifan 100 mg versus four 25 mg tablets under fasting conditions in healthy adult participants, and to evaluate the effect of food on the single-dose PK of casdatifan 100 mg administered as four 25 mg tablets in healthy adult participants.
Interventions
- DRUG Casdatifan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-05-29 |
| Est. Completion | 2026-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07641881
The ClinicalTrials.gov registry entry for NCT07641881 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arcus Biosciences, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Casdatifan is the first listed.
NCT07641881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07641881 about?
NCT07641881 is a clinical study titled "A Bioequivalence Study Between Two Casdatifan Tablet Strengths and Food Effect Study of Casdatifan in Healthy Adult Participants". The purpose of this study is to compare the single-dose pharmacokinetics (PK) of casdatifan 100 mg versus four 25 mg tablets under fasting conditions in healthy adult participants, and to evaluate the effect of food on the single-dose PK of casdatifan 100 mg administered as four 25 mg tablets in hea...
What is the current status of trial NCT07641881?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2026-05-29. Estimated completion is 2026-07.
What interventions are being tested in trial NCT07641881?
The interventions under investigation include: Casdatifan (DRUG).
Who is sponsoring clinical trial NCT07641881?
This trial is sponsored by Arcus Biosciences, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.